Breast Cancer Research and Treatment (Запис № 457518)

МАРК-запис
000 -LEADER
fixed length control field 02914nas a22002895i 4500
001 - CONTROL NUMBER
control field 1573-7217
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200203195213.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150723s||||||||xxuuu poo|||||| b|EN |d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1573-7217
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/10549.1573-7217
Source of number or code doi
210 10 - ABBREVIATED TITLE
Abbreviated title Breast Cancer Res Treat
245 10 - TITLE STATEMENT
Title Breast Cancer Research and Treatment
Medium [electronic resource] /
Statement of responsibility, etc edited by William J. Gradishar.
264 #1 -
-- New York :
-- Springer US :
-- Imprint: Springer.
300 ## - PHYSICAL DESCRIPTION
Other physical details online resource.
520 ## - SUMMARY, ETC.
Summary, etc Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer. Oncology is undoubtedly one of the largest subspecialties in the field of medicine, and breast cancer is one of the most serious problems. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Breast Cancer Research and Treatment is an international arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics. There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
-- http://scigraph.springernature.com/things/product-market-codes/H33160
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gradishar, William J.
Relator term editor.
Relator code edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed version:
International Standard Serial Number 0167-6806
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/10549.1573-7217">https://doi.org/10.1007/10549.1573-7217</a>
Public note Hybrid
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type ЕЖурнал

Немає доступних примірників.